A passion for medical technology and ensuring the availability of optimal total solutions in all circumstances. Acertys, as a partner for hospitals and medical professionals, only wants what is best for both staff and patients.
Esaote is one of the world’s leading producers of medical diagnostic systems and internationally acknowledged to be the world leader in dedicated MRI. The Esaote Group is also one of the main players in the sector of Information Technology for healthcare.
SonoSite, Inc. (www.sonosite.com ), a subsidiary of FUJIFILM, is the innovator and world leader in bedside and point-of-care ultrasound and an industry leader in ultra high-frequency micro-ultrasound technology and impedance cardiography equipment. Headquartered near Seattle, the company is represented by ten subsidiaries and a global distribution network in over 100 countries. SonoSite's small, lightweight systems are expanding the use of ultrasound across the clinical spectrum by cost-effectively bringing high-performance ultrasound to the point of patient care. Size is everything for SonoSite. The firm makes handheld ultrasonic imaging devices that health care providers can use outside traditional imaging facilities, for instance, in the ER, at a patient's bedside, or in the doctor's office. Its fourth- and fifth-generation systems include the handheld NanoMaxx tool and the M-Turbo and Edge portable consoles that produce imaging quality comparable to larger cart-based systems. Its S Series of products feature customized interfaces for different clinical applications, including the ER or the ICU.
Our mission is to improve the health and well-being of patients around the world
Grifols is a global healthcare company founded in Barcelona, with more than 100 years of history, dedicated to improving the health and well-being of people around the world.
We are an industry leader in the production of plasma-derived medicines and transfusion medicine, with more than 21,000 employees across 30 countries.
Our business continues to grow, we remain committed to a long-term, sustainable and responsible vision.
Teva Pharmaceutical Industries Limited develops, manufactures, markets, and distributes generic medicines and a portfolio of specialty medicines worldwide. It operates through two segments, Generic Medicines and Specialty Medicines. The Generic Medicines segment offers sterile products, hormones, narcotics, high-potency drugs, and cytotoxic substances in various dosage forms, including tablets, capsules, injectables, inhalants, liquids, ointments, and creams. This segment also develops, manufactures, and sells active pharmaceutical ingredients. The Specialty Medicines segment provides branded specialty medicines for use in central nervous system and respiratory indications, as well as the womens health, oncology, and other specialty businesses. Its products in the central nervous system area comprise Copaxone for multiple sclerosis; Azilect for the treatment of Parkinsons disease; and Nuvigil for the treatment of excessive sleepiness associated with narcolepsy and certain other disorders. This segments products in the respiratory market include ProAir, ProAir Respiclick, QVAR, Duoresp Spiromax, Qnasl, Braltus, Cinqair/Cinqaero, and Aerivio Spiromax for the treatment of asthma and chronic obstructive pulmonary disease, as well as Treanda/Bendeka, Granix, Trisenox, Lonquex, and Tevagrastim/Ratiograstim products in the oncology market. This segment also offers a portfolio of products in the womens health category, which includes ParaGard, Plan B One-Step, and OTC/Rx, as well as other products. The company has collaboration arrangements with Attenukine, Procter & Gamble Company, and Regeneron Pharmaceuticals, Inc. Teva Pharmaceutical Industries Limited was founded in 1901 and is headquartered in Petach Tikva, Israel.